CELL INTELLIGENCE · 肿瘤细胞治疗研究

CD200-CD200R 作为实体瘤中的髓系免疫检查点：机制、情境依赖性功能及治疗机会

CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities.

基于 mRNA 的实体瘤癌症疫苗的临床转化

Clinical translation of mRNA-based cancer vaccines for solid tumors.

指导基于 NK 细胞的实体瘤适应症的多模式框架

A Multimodal Framework to Guide Solid Tumor Indications for Natural Killer Cell-Based Therapy.

实体瘤与血液系统恶性肿瘤中的肿瘤免疫治疗：进展、挑战与实践框架

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

线粒体膜电位反映癌症免疫治疗过程中 T 细胞的适应性和功能

Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy.

一种益生菌调节肺癌中的抗肿瘤γδ T 细胞反应

A probiotic bacterium modulates antitumour γδ T-cell responses in lung cancer.

创新免疫治疗方法：利用肿瘤学中双重检查点阻断的协同作用

Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology.

B 细胞在肿瘤免疫中发挥重要作用

B cells are major players in cancer immunity.

S1PR1 受体在多种人类癌症中的生物信息学探索及其临床相关性

Bioinformatics exploration of the S1PR1 receptor in various human cancers and its clinical relevance.

S1PR1 通过其表达、突变和修饰在癌症进展中发挥关键作用。这些发现表明，S1PR1 可作为癌症潜在的生物标志物和治疗靶点，但需要在临床环境中进一步验证。

免疫肿瘤治疗药物的临床开发

Clinical development of immuno-oncology therapeutics.